Literature DB >> 24226096

Addressing the American health-care cost crisis: role of the oncology community.

Scott D Ramsey1, Patricia A Ganz, Veena Shankaran, Jeffrey Peppercorn, Ezekiel Emanuel.   

Abstract

Health-care cost growth is unsustainable, and the current level of spending is harming our economy and our patients. This commentary describes the scope of the health-care spending problem and the particular factors in cancer care that contribute to the problem, reflecting in part presentations and discussions from an Institute of Medicine National Cancer Policy Forum Workshop held in October 2012. Presenters at the workshop identified a number of steps that the oncology community can take to reduce the rate of growth in cancer-care costs while maintaining or improving upon the quality of care. This commentary aims to highlight opportunities for the oncology community to take a leadership role in delivering affordable, high-quality cancer care.

Entities:  

Mesh:

Year:  2013        PMID: 24226096     DOI: 10.1093/jnci/djt293

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Communication with Physicians about Health Care Costs: Survey of an Insured Population.

Authors:  Nora B Henrikson; Eva Chang; Kevin Ulrich; Deborah King; Melissa L Anderson
Journal:  Perm J       Date:  2017

2.  The imperative to address the cost of oncology care.

Authors:  Neal J Meropol
Journal:  J Natl Cancer Inst       Date:  2013-11-13       Impact factor: 13.506

3.  Early Accountable Care Organization Results in End-of-Life Spending Among Cancer Patients.

Authors:  Miranda B Lam; Jie Zheng; E John Orav; Ashish K Jha
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

4.  The intersection of financial toxicity and family building in young adult cancer survivors.

Authors:  Bridgette Thom; Catherine Benedict; Danielle N Friedman; Joanne F Kelvin
Journal:  Cancer       Date:  2018-06-20       Impact factor: 6.860

5.  Patient experience and attitudes toward addressing the cost of breast cancer care.

Authors:  Blair Irwin; Gretchen Kimmick; Ivy Altomare; P Kelly Marcom; Kevin Houck; S Yousuf Zafar; Jeffrey Peppercorn
Journal:  Oncologist       Date:  2014-10-01

6.  Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective?

Authors:  Neil T Phippen; Charles A Leath; Laura J Havrilesky; Jason C Barnett
Journal:  Gynecol Oncol       Date:  2014-11-09       Impact factor: 5.482

7.  Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

Authors:  Scott K Sherman; Joel J Lange; Fadi S Dahdaleh; Rahul Rajeev; T Clark Gamblin; Blase N Polite; Kiran K Turaga
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

8.  Design, data linkage, and implementation considerations in the first cooperative group led study assessing financial outcomes in cancer patients and their informal caregivers.

Authors:  Veena Shankaran; Joseph M Unger; Amy K Darke; Dawn L Hershman; Scott D Ramsey
Journal:  Contemp Clin Trials       Date:  2020-05-30       Impact factor: 2.226

9.  Translation in solid cancer: are size-based response criteria an anachronism?

Authors:  M Fernandes; D Rosel; J Brábek
Journal:  Clin Transl Oncol       Date:  2014-07-30       Impact factor: 3.405

10.  Second-opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care.

Authors:  Vaios Hatzoglou; Antonio M Omuro; Sofia Haque; Yasmin Khakoo; Ian Ganly; Jung Hun Oh; Amita Shukla-Dave; Robin Fatovic; Joshua Gaal; Andrei I Holodny
Journal:  Cancer       Date:  2016-05-24       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.